Prague Med. Rep. 2016, 117, 81-89

https://doi.org/10.14712/23362936.2016.8

Smoking Prevalence and Its Clinical Correlations in Patients with Narcolepsy-cataplexy

Pavla Peřinová1, Eva Feketeová2, David Kemlink1, Petra Kovalská1, Karolína Chlebušová1, Jiří Nepožitek1, Veronika Ibarburu1, Eva Králíková3,4, Soňa Nevšímalová1, Karel Šonka1

1Centre for Sleep and Wake Disorders, Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
2Department of Neurology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice and Louis Pasteur University Hospital, Košice, Slovak Republic
3Centre for Tobacco-Dependent, 3rd Department of Medicine – Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
4Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

Received January 15, 2016
Accepted September 2, 2016

References

1. American Academy of Sleep Medicine (2005) International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd Ed. American Academy of Sleep Medicine, Westchester.
2. Arand, D., Bonnet, M., Hurwitz, T., Mitler, M., Rosa, R., Sangal, R. B. (2005) The clinical use of the MSLT and MWT. Sleep 28, 123–144. <https://doi.org/10.1093/sleep/28.1.123>
3. Barateau, L., Jaussent, I., Lopez, R., Boutrel, B., Leu-Semenescu, S., Arnulf, I., Dauvilliers, Y. (2016) Smoking, alcohol, drug use, abuse and dependence in narcolepsy and idiopathic hypersomnia: a case-control study. Sleep 39, 573–580. <https://doi.org/10.5665/sleep.5530> <PubMed>
4. Benowitz, N. L. (2008) Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin. Pharmacol. Ther. 83, 531–541. <https://doi.org/10.1038/clpt.2008.3>
5. Boutrel, B., Koob, G. F. (2004) What keeps us awake: The neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 27, 1181–1194. <https://doi.org/10.1093/sleep/27.6.1181>
6. Carlens, C., Hergens, M. P., Grunewald, J., Ekbom, A., Eklund, A., Hoglund, C. O., Askling, J. (2010) Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am. J. Respir. Crit. Care Med. 181, 1217–1222. <https://doi.org/10.1164/rccm.200909-1338OC>
7. Corrigall, W. A. (2009) Hypocretin mechanisms in nicotine addiction: evidence and speculation. Psychopharmacology (Berl.) 206, 23–37. <https://doi.org/10.1007/s00213-009-1588-2>
8. Dauvilliers, Y., Montplaisir, J., Molinari, N., Carlander, B., Ondze, B., Besset, A., Billiard, M. (2001) Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 57, 2029–2033. <https://doi.org/10.1212/WNL.57.11.2029>
9. Dauvilliers, Y., Arnulf, I., Mignot, E. (2007) Narcolepsy with cataplexy. Lancet 369, 499–511. <https://doi.org/10.1016/S0140-6736(07)60237-2>
10. Dimitrova, A., Fronczek, R., Van der Ploeg, J., Scammell, T., Gautam, S., Pascual-Leone, A., Lammers, G. J. (2011) Reward-seeking behavior in human narcolepsy. J. Clin. Sleep Med. 7, 293–300.
11. Ebben, M. R., Krieger, A. C. (2012) Narcolepsy with cataplexy masked by the use of nicotine. J. Clin. Sleep Med. 8, 195–196.
12. Engleman, H. M., Douglas, N. J. (2004) Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax 59, 618–622. <https://doi.org/10.1136/thx.2003.015867> <PubMed>
13. Fortuyn, H. A., Lappenschaar, M. A., Furer, J. W., Hodiamont, P. P., Rijnders, C. A. T., Renier, W. O., Buitelaar, J. K., Overeem, S. (2010) Anxiety and mood disorders in narcolepsy: a case-control study. Gen. Hosp. Psychiatry 32, 49–56. <https://doi.org/10.1016/j.genhosppsych.2009.08.007>
14. Hallmayer, J., Faraco, J., Lin, L., Hesselson, S., Winkelmann, J., Kawashima, M., Mayer, G., Plazz, G., Nevsimalova, S., Bourgin, P., Hong, S. C., Honda, Y., Honda, M., Högl, B., Longstreth, W. T. Jr., Montplaisir, J., Kemlink, D., Einen, M., Chen, J., Musone, S. L., Akana, M., Miyagawa, T., Duan, J., Desautels, A., Erhardt, C., Hesla, P. E., Poli, F., Frauscher, B., Jeong, J. H., Lee, S. P., Ton, T. G., Kvale, M., Kolesar, L., Dobrovolná, M., Nepom, G. T., Salomon, D., Wichmann, H. E., Rouleau, G. A., Gieger, C., Levinson, D. F., Gejman, P. V., Meitinger, T., Young, T., Peppard, P., Tokunaga, K., Kwok, P. Y., Risch, N., Mignot, E. (2009) Narcolepsy is strongly associated with T-cell receptor alpha locus. Nat. Genet. 41, 708–711. <https://doi.org/10.1038/ng.372> <PubMed>
15. Hedstrom, K. A., Hillert, J., Olsson, T., Alfredsson, L. (2013) Smoking and multiple sclerosis susceptibility. Eur. J. Epidemiol. 28, 867–887. <https://doi.org/10.1007/s10654-013-9853-4> <PubMed>
16. Hornyak, M., Feige, B., Riemann, D., Voderholzer, U. (2006) Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment. Sleep Med. Rev. 10, 169–177. <https://doi.org/10.1016/j.smrv.2005.12.003>
17. Iber, C., Ancoli-Israel, S., Chesson, A., Quan, S. F. (2007) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, 1st Ed. American Academy of Sleep Medicine, Westchester.
18. Jaehne, A., Loessl, A. B., Bárkai, Z., Riemann, D., Hornyak, M. (2009) Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Med. Rev. 13, 363–377. <https://doi.org/10.1016/j.smrv.2008.12.003>
19. Jennum, P., Ibsen, R., Knudsen, S., Kjellberg, J. (2013) Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study. Sleep 36, 835–840.
20. Johns, M. W. (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14, 540–545. <https://doi.org/10.1093/sleep/14.6.540>
21. Krahn, L. E., Martin, K. A., Silber, M. H. (2009) Narcoleptic patients’ perceptions of nicotine. J. Clin. Sleep Med. 5, 390.
22. Liblau, R. S., Vassalli, A., Seifinejad, A., Tafti, M. (2015) Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol. 14, 318–328. <https://doi.org/10.1016/S1474-4422(14)70218-2>
23. Mignot, E. (1998) Genetic and familial aspects of narcolepsy. Neurology 50, 16–22. <https://doi.org/10.1212/WNL.50.2_Suppl_1.S16>
24. Ohayon, M. M. (2013) Narcolepsy is complicated by high medical a psychiatric comorbidities: a comparison with the general population. Sleep Med. 14, 488–492. <https://doi.org/10.1016/j.sleep.2013.03.002>
25. Ohayon, M. M., Priest, R. G., Zulley, J., Smirne, S., Paiva, T. (2002) Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 58, 1826–1833. <https://doi.org/10.1212/WNL.58.12.1826>
26. Palaia, V., Poli, F., Pizza, F., Antelmi, E., Franceschini, C., Moghadam, K. K., Provini, F., Pagotto, U., Montagna, P., Schenck, C. H., Mignot, E., Plazzi, G. (2011) Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: a case-control study. Sleep 34, 1365–1371. <https://doi.org/10.5665/SLEEP.1280> <PubMed>
27. Partinen, M., Kornum, B. R., Plazzi, G., Jennum, P., Julkunen, I., Vaarala, O. (2014) Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 13, 600–613. <https://doi.org/10.1016/S1474-4422(14)70075-4>
28. Plaza-Zabala, A., Flores, A., Martín-García, E., Saravia, R., Maldonado, R., Berrendero, F. (2013) A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior. Neuropsychopharmacology 38, 1724–1736. <https://doi.org/10.1038/npp.2013.72> <PubMed>
29. Prosise, G. L., Bonnet, M. H., Berry, R. B., Dickel, M. J. (1994) Effects of abstinence from smoking on sleep and daytime sleepiness. Chest 105, 1136–1141. <https://doi.org/10.1378/chest.105.4.1136>
30. Sansa, G., Iranzo, A., Santamaria, J. (2010) Obstructive sleep apnea in narcolepsy. Sleep Med. 11, 93–95. <https://doi.org/10.1016/j.sleep.2009.02.009>
31. Šonka, K., Tafti, M., Billiard, M. (1993) Polysomnografické nálezy u narkoleptiků středního a vyššího věku. Sb. Lek. 94, 333–344.
32. Sonka, K., Kemlink, D., Buskova, J., Pretl, M., Srutkova, Z., Maurovich Horvat, E., Vodicka, P., Polakova, V., Nevsimalova, S. (2010) Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy. Neuro Endocrinol. Lett. 31, 631–634.
33. Sovinová, H., Csémy, L. (2015) The Use of Tobacco and Alcohol in the Czech Republic 2014. National Institute of Public Health, Prague; available at: http://www.szu.cz/uploads/documents/czzp/zavislosti/TabAlkCZ_EN2014.pdf
34. Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., Siegel, J. M. (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469–474. <https://doi.org/10.1016/S0896-6273(00)00058-1>
35. Tizabi, Y., Overstreet, D. H., Rezvani, A. H., Louis, V. A., Clark, E. Jr., Janowsky, D. S., Kling, M. A. (1999) Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 142, 193–199. <https://doi.org/10.1007/s002130050879>
36. Ton, G. N. T., Longstreth, W. T. Jr., Koepsell, T. (2009) Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: A population-based case-control study. Neuroepidemiology 32, 114–121. <https://doi.org/10.1159/000177037> <PubMed>
37. Vourdas, A., Shneerson, J. M., Gregory, C. A., Smith, I. E., King, M. A., Morrish, E., McKenna, P. J. (2002) Narcolepsy and psychopathology: Is there an association? Sleep Med. 3, 353–360. <https://doi.org/10.1016/S1389-9457(02)00062-X>
38. WHO (2008) MPOWER; available at: http://www.who.int/tobacco/mpower/en/
39. Wingerchuk, D. M. (2012) Smoking: Effects on multiple sclerosis susceptibility and disease progression. Ther. Adv. Neurol. Disord. 5, 13–22. <https://doi.org/10.1177/1756285611425694> <PubMed>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive